273 related articles for article (PubMed ID: 18537664)
21. Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain.
Hoozemans JJ; Rozemuller AJ; Janssen I; De Groot CJ; Veerhuis R; Eikelenboom P
Acta Neuropathol; 2001 Jan; 101(1):2-8. PubMed ID: 11194936
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of COX inhibitors against beta-amyloid-induced neurotoxicity in human neuroblastoma cells.
Ferrera P; Arias C
Neurochem Int; 2005 Dec; 47(8):589-96. PubMed ID: 16169124
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase as a target for the antiamyloidogenic activities of nonsteroidal anti-inflammatory drugs in Alzheimer's disease.
Pasinetti GM
Neurosignals; 2002; 11(5):293-7. PubMed ID: 12566930
[TBL] [Abstract][Full Text] [Related]
24. Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease.
Ozben T; Ozben S
Clin Biochem; 2019 Oct; 72():87-89. PubMed ID: 30954437
[TBL] [Abstract][Full Text] [Related]
25. Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease.
Klegeris A; McGeer PL
Curr Alzheimer Res; 2005 Jul; 2(3):355-65. PubMed ID: 15974901
[TBL] [Abstract][Full Text] [Related]
26. Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.
Gasparini L; Ongini E; Wilcock D; Morgan D
Brain Res Brain Res Rev; 2005 Apr; 48(2):400-8. PubMed ID: 15850679
[TBL] [Abstract][Full Text] [Related]
27. A role for cyclooxygenase-1 in beta-amyloid-induced neuroinflammation.
Candelario-Jalil E
Aging (Albany NY); 2009 Apr; 1(4):350-3. PubMed ID: 20157521
[No Abstract] [Full Text] [Related]
28. An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease.
Imbimbo BP
Expert Opin Investig Drugs; 2009 Aug; 18(8):1147-68. PubMed ID: 19589092
[TBL] [Abstract][Full Text] [Related]
29. Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons.
Yermakova AV; Rollins J; Callahan LM; Rogers J; O'Banion MK
J Neuropathol Exp Neurol; 1999 Nov; 58(11):1135-46. PubMed ID: 10560656
[TBL] [Abstract][Full Text] [Related]
30. The role of cyclo-oxygenase 1 and 2 activity in prostaglandin E(2) secretion by cultured human adult microglia: implications for Alzheimer's disease.
Hoozemans JJ; Veerhuis R; Janssen I; van Elk EJ; Rozemuller AJ; Eikelenboom P
Brain Res; 2002 Oct; 951(2):218-26. PubMed ID: 12270500
[TBL] [Abstract][Full Text] [Related]
31. Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer's Disease Model Mice.
Shukuri M; Mawatari A; Ohno M; Suzuki M; Doi H; Watanabe Y; Onoe H
J Nucl Med; 2016 Feb; 57(2):291-6. PubMed ID: 26585055
[TBL] [Abstract][Full Text] [Related]
32. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
Jaturapatporn D; Isaac MG; McCleery J; Tabet N
Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
[TBL] [Abstract][Full Text] [Related]
33. Coxibs and Alzheimer's disease: should they stay or should they go?
Firuzi O; Praticò D
Ann Neurol; 2006 Feb; 59(2):219-28. PubMed ID: 16402383
[TBL] [Abstract][Full Text] [Related]
34. Neurones treated with cyclo-oxygenase-1 inhibitors are resistant to amyloid-beta1-42.
Bate C; Veerhuis R; Eikelenboom P; Williams A
Neuroreport; 2003 Nov; 14(16):2099-103. PubMed ID: 14600505
[TBL] [Abstract][Full Text] [Related]
35. The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer's disease.
Imbimbo BP
Expert Opin Investig Drugs; 2004 Nov; 13(11):1469-81. PubMed ID: 15500394
[TBL] [Abstract][Full Text] [Related]
36. Integrated communications between cyclooxygenase-2 and Alzheimer's disease.
Guan PP; Wang P
FASEB J; 2019 Jan; 33(1):13-33. PubMed ID: 30020833
[TBL] [Abstract][Full Text] [Related]
37. COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs.
Mitchell JA; Warner TD
Nat Rev Drug Discov; 2006 Jan; 5(1):75-86. PubMed ID: 16485347
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo profiling of CHF5022 and CHF5074 Two beta-amyloid1-42 lowering agents.
Imbimbo BP; Del Giudice E; Cenacchi V; Volta R; Villetti G; Facchinetti F; Riccardi B; Puccini P; Moretto N; Grassi F; Ottonello S; Leon A
Pharmacol Res; 2007 Apr; 55(4):318-28. PubMed ID: 17292621
[TBL] [Abstract][Full Text] [Related]
39. NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development?
Weggen S; Rogers M; Eriksen J
Trends Pharmacol Sci; 2007 Oct; 28(10):536-43. PubMed ID: 17900710
[TBL] [Abstract][Full Text] [Related]
40. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.
van Groen T; Miettinen P; Kadish I
J Alzheimers Dis; 2011; 24(2):301-13. PubMed ID: 21239852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
